25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

IBKS No2 SPAC
Buy, Hold or Sell?

Let's analyze IBKS No2 SPAC together

I guess you are interested in IBKS No2 SPAC. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of IBKS No2 SPAC. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about IBKS No2 SPAC

I send you an email if I find something interesting about IBKS No2 SPAC.

1. Quick Overview

1.1. Quick analysis of IBKS No2 SPAC (30 sec.)










1.2. What can you expect buying and holding a share of IBKS No2 SPAC? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩159.79
Expected worth in 1 year
₩-38.38
How sure are you?
55.6%

+ What do you gain per year?

Total Gains per Share
₩-198.17
Return On Investment
-20.4%

For what price can you sell your share?

Current Price per Share
₩973.00
Expected price per share
₩837.00 - ₩1,106
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of IBKS No2 SPAC (5 min.)




Live pricePrice per Share (EOD)
₩973.00
Intrinsic Value Per Share
₩-591.90 - ₩-259.44
Total Value Per Share
₩-432.11 - ₩-99.65

2.2. Growth of IBKS No2 SPAC (5 min.)




Is IBKS No2 SPAC growing?

Current yearPrevious yearGrowGrow %
How rich?$8.5m$11.2m-$2.6m-31.0%

How much money is IBKS No2 SPAC making?

Current yearPrevious yearGrowGrow %
Making money-$2.6m-$553.1k-$2m-78.9%
Net Profit Margin-14.4%-4.7%--

How much money comes from the company's main activities?

2.3. Financial Health of IBKS No2 SPAC (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of IBKS No2 SPAC?

Welcome investor! IBKS No2 SPAC's management wants to use your money to grow the business. In return you get a share of IBKS No2 SPAC.

First you should know what it really means to hold a share of IBKS No2 SPAC. And how you can make/lose money.

Speculation

The Price per Share of IBKS No2 SPAC is ₩973.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of IBKS No2 SPAC.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in IBKS No2 SPAC, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩159.79. Based on the TTM, the Book Value Change Per Share is ₩-49.54 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-9.87 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of IBKS No2 SPAC.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.030.0%-0.030.0%-0.010.0%-0.030.0%-0.030.0%
Usd Book Value Change Per Share-0.030.0%-0.030.0%-0.010.0%0.010.0%0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.030.0%-0.030.0%-0.010.0%0.010.0%0.010.0%
Usd Price Per Share0.80-0.80-0.53-0.79-1.48-
Price to Earnings Ratio-23.29--23.29--72.96--34.07-977.34-
Price-to-Total Gains Ratio-22.93--22.93--75.97--13.49-9.16-
Price to Book Ratio7.11-7.11-3.58-11.99-25.33-
Price-to-Total Gains Ratio-22.93--22.93--75.97--13.49-9.16-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.6811
Number of shares1468
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.030.01
Usd Total Gains Per Share-0.030.01
Gains per Quarter (1468 shares)-50.9111.94
Gains per Year (1468 shares)-203.6447.76
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-204-21404838
20-407-41809686
30-611-6220143134
40-815-8260191182
50-1018-10300239230
60-1222-12340287278
70-1426-14380334326
80-1629-16420382374
90-1833-18460430422
100-2036-20500478470

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%1.08.00.011.1%1.08.00.011.1%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.04.00.055.6%5.04.00.055.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.09.00.0%0.00.09.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.04.00.055.6%5.04.00.055.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of IBKS No2 SPAC compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---49.544-49.5440%-9.872-80%11.619-526%17.754-379%
Book Value Per Share--159.790159.7900%209.334-24%161.057-1%126.342+26%
Current Ratio--1.3491.3490%1.236+9%1.558-13%1.827-26%
Debt To Asset Ratio--0.6920.6920%0.606+14%0.654+6%0.620+12%
Debt To Equity Ratio--2.2462.2460%1.539+46%3.272-31%2.609-14%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--59732901930.00059732901930.0000%37524496100.000+59%69010459376.000-13%150081237631.249-60%
Eps---48.767-48.7670%-10.280-79%-44.592-9%-46.549-5%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--2.2952.2950%2.243+2%5.123-55%29.464-92%
Free Cash Flow Per Share---56.448-56.4480%-100.355+78%-55.906-1%-50.161-11%
Free Cash Flow To Equity Per Share---56.448-56.4480%-21.375-62%-10.003-82%-7.876-86%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---259.436--------
Intrinsic Value_10Y_min---591.898--------
Intrinsic Value_1Y_max---49.569--------
Intrinsic Value_1Y_min---66.418--------
Intrinsic Value_3Y_max---130.970--------
Intrinsic Value_3Y_min---194.588--------
Intrinsic Value_5Y_max---190.715--------
Intrinsic Value_5Y_min---316.325--------
Market Cap74789839600.000-17%87318867200.00087318867200.0000%57648900000.000+51%87257375040.000+0%162877390400.138-46%
Net Profit Margin---0.144-0.1440%-0.047-67%-0.258+79%-0.544+278%
Operating Margin----0%-0.1950%-0.1860%-0.4120%
Operating Ratio--1.7891.7890%1.903-6%1.672+7%2.126-16%
Pb Ratio6.089-17%7.1097.1090%3.583+98%11.987-41%25.332-72%
Pe Ratio-19.952+14%-23.294-23.2940%-72.958+213%-34.072+46%977.342-102%
Price Per Share973.000-17%1136.0001136.0000%750.000+51%1135.200+0%2119.000-46%
Price To Free Cash Flow Ratio-17.237+14%-20.125-20.1250%-7.473-63%-24.930+24%-24.925+24%
Price To Total Gains Ratio-19.639+14%-22.929-22.9290%-75.970+231%-13.494-41%9.164-350%
Quick Ratio--0.4560.4560%0.775-41%1.047-56%1.821-75%
Return On Assets---0.094-0.0940%-0.019-79%-0.107+14%-0.159+69%
Return On Equity---0.305-0.3050%-0.049-84%-0.629+106%-0.575+89%
Total Gains Per Share---49.544-49.5440%-9.872-80%11.619-526%17.754-379%
Usd Book Value--8597609.6718597609.6710%11263342.510-24%8665769.223-1%6797911.309+26%
Usd Book Value Change Per Share---0.035-0.0350%-0.007-80%0.008-526%0.012-379%
Usd Book Value Per Share--0.1120.1120%0.147-24%0.113-1%0.088+26%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--41813031.35141813031.3510%26267147.270+59%48307321.563-13%105056866.342-60%
Usd Eps---0.034-0.0340%-0.007-79%-0.031-9%-0.033-5%
Usd Free Cash Flow---3037236.223-3037236.2230%-5399667.903+78%-3008036.592-1%-2698918.234-11%
Usd Free Cash Flow Per Share---0.040-0.0400%-0.070+78%-0.039-1%-0.035-11%
Usd Free Cash Flow To Equity Per Share---0.040-0.0400%-0.015-62%-0.007-82%-0.006-86%
Usd Market Cap52352887.720-17%61123207.04061123207.0400%40354230.000+51%61080162.528+0%114014173.280-46%
Usd Price Per Share0.681-17%0.7950.7950%0.525+51%0.795+0%1.483-46%
Usd Profit---2623960.283-2623960.2830%-553117.117-79%-2399316.504-9%-2504589.699-5%
Usd Revenue--18223117.75218223117.7520%11709952.079+56%10889710.150+67%7723785.176+136%
Usd Total Gains Per Share---0.035-0.0350%-0.007-80%0.008-526%0.012-379%
 EOD+3 -5MRQTTM+0 -0YOY+14 -215Y+9 -2610Y+12 -23

3.3 Fundamental Score

Let's check the fundamental score of IBKS No2 SPAC based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-19.952
Price to Book Ratio (EOD)Between0-16.089
Net Profit Margin (MRQ)Greater than0-0.144
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.456
Current Ratio (MRQ)Greater than11.349
Debt to Asset Ratio (MRQ)Less than10.692
Debt to Equity Ratio (MRQ)Less than12.246
Return on Equity (MRQ)Greater than0.15-0.305
Return on Assets (MRQ)Greater than0.05-0.094
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of IBKS No2 SPAC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.109
Ma 20Greater thanMa 50984.050
Ma 50Greater thanMa 100993.460
Ma 100Greater thanMa 2001,038.300
OpenGreater thanClose960.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About IBKS No2 SPAC

GL Pharm Tech Corp. provides generic drugs and incrementally modified drug (IMD) formulation technology to pharmaceutical companies in South Korea. The company offers IMD for gastritis, antidepressant, anorectic, and antibiotic indications. It also provides generic drugs for cardiovascular, urology, pain, anti-infection, gastric disease, diabetes, central nervous system disease, respiratory disease, transplantation, and other areas. In addition, the company engages in developing new molecule entity pipeline products for dry eye disease. Further, it provides Cabalin CR extended-release tablet and Jample Ibufen syrup for the nervous system and sensory organs; Gisoren tablets for individual organs, digestive system, and peptic ulcer drugs; and Genstring Troki for treating individual organs and digestive system, as well as oral use. GL Pharm Tech Corp. was founded in 2002 and is headquartered in Seongnam-si, South Korea.

Fundamental data was last updated by Penke on 2025-01-21 13:39:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit IBKS No2 SPAC earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare IBKS No2 SPAC to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -14.4% means that ₩-0.14 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of IBKS No2 SPAC:

  • The MRQ is -14.4%. The company is making a huge loss. -2
  • The TTM is -14.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-14.4%TTM-14.4%0.0%
TTM-14.4%YOY-4.7%-9.7%
TTM-14.4%5Y-25.8%+11.4%
5Y-25.8%10Y-54.4%+28.6%
4.3.1.2. Return on Assets

Shows how efficient IBKS No2 SPAC is using its assets to generate profit.

  • Above 5% is considered healthy but always compare IBKS No2 SPAC to the Drug Manufacturers - Specialty & Generic industry mean.
  • -9.4% Return on Assets means that IBKS No2 SPAC generated ₩-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of IBKS No2 SPAC:

  • The MRQ is -9.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.4%TTM-9.4%0.0%
TTM-9.4%YOY-1.9%-7.5%
TTM-9.4%5Y-10.7%+1.3%
5Y-10.7%10Y-15.9%+5.2%
4.3.1.3. Return on Equity

Shows how efficient IBKS No2 SPAC is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare IBKS No2 SPAC to the Drug Manufacturers - Specialty & Generic industry mean.
  • -30.5% Return on Equity means IBKS No2 SPAC generated ₩-0.31 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of IBKS No2 SPAC:

  • The MRQ is -30.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -30.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-30.5%TTM-30.5%0.0%
TTM-30.5%YOY-4.9%-25.6%
TTM-30.5%5Y-62.9%+32.4%
5Y-62.9%10Y-57.5%-5.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of IBKS No2 SPAC.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient IBKS No2 SPAC is operating .

  • Measures how much profit IBKS No2 SPAC makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare IBKS No2 SPAC to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of IBKS No2 SPAC:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-19.5%+19.5%
TTM-5Y-18.6%+18.6%
5Y-18.6%10Y-41.2%+22.7%
4.3.2.2. Operating Ratio

Measures how efficient IBKS No2 SPAC is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.79 means that the operating costs are ₩1.79 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of IBKS No2 SPAC:

  • The MRQ is 1.789. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.789. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.789TTM1.7890.000
TTM1.789YOY1.903-0.114
TTM1.7895Y1.672+0.118
5Y1.67210Y2.126-0.454
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of IBKS No2 SPAC.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if IBKS No2 SPAC is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.35 means the company has ₩1.35 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of IBKS No2 SPAC:

  • The MRQ is 1.349. The company is just able to pay all its short-term debts.
  • The TTM is 1.349. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.349TTM1.3490.000
TTM1.349YOY1.236+0.114
TTM1.3495Y1.558-0.209
5Y1.55810Y1.827-0.269
4.4.3.2. Quick Ratio

Measures if IBKS No2 SPAC is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare IBKS No2 SPAC to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.46 means the company can pay off ₩0.46 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of IBKS No2 SPAC:

  • The MRQ is 0.456. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.456. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.456TTM0.4560.000
TTM0.456YOY0.775-0.319
TTM0.4565Y1.047-0.591
5Y1.04710Y1.821-0.774
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of IBKS No2 SPAC.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of IBKS No2 SPAC assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare IBKS No2 SPAC to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.69 means that IBKS No2 SPAC assets are financed with 69.2% credit (debt) and the remaining percentage (100% - 69.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of IBKS No2 SPAC:

  • The MRQ is 0.692. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.692. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.692TTM0.6920.000
TTM0.692YOY0.606+0.086
TTM0.6925Y0.654+0.038
5Y0.65410Y0.620+0.035
4.5.4.2. Debt to Equity Ratio

Measures if IBKS No2 SPAC is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare IBKS No2 SPAC to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 224.6% means that company has ₩2.25 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of IBKS No2 SPAC:

  • The MRQ is 2.246. The company is just not able to pay all its debts with equity.
  • The TTM is 2.246. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.246TTM2.2460.000
TTM2.246YOY1.539+0.707
TTM2.2465Y3.272-1.026
5Y3.27210Y2.609+0.663
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings IBKS No2 SPAC generates.

  • Above 15 is considered overpriced but always compare IBKS No2 SPAC to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -23.29 means the investor is paying ₩-23.29 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of IBKS No2 SPAC:

  • The EOD is -19.952. Based on the earnings, the company is expensive. -2
  • The MRQ is -23.294. Based on the earnings, the company is expensive. -2
  • The TTM is -23.294. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-19.952MRQ-23.294+3.342
MRQ-23.294TTM-23.2940.000
TTM-23.294YOY-72.958+49.664
TTM-23.2945Y-34.072+10.778
5Y-34.07210Y977.342-1,011.413
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of IBKS No2 SPAC:

  • The EOD is -17.237. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -20.125. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -20.125. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-17.237MRQ-20.125+2.888
MRQ-20.125TTM-20.1250.000
TTM-20.125YOY-7.473-12.651
TTM-20.1255Y-24.930+4.805
5Y-24.93010Y-24.925-0.005
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of IBKS No2 SPAC is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 7.11 means the investor is paying ₩7.11 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of IBKS No2 SPAC:

  • The EOD is 6.089. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.109. Based on the equity, the company is overpriced. -1
  • The TTM is 7.109. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.089MRQ7.109-1.020
MRQ7.109TTM7.1090.000
TTM7.109YOY3.583+3.527
TTM7.1095Y11.987-4.878
5Y11.98710Y25.332-13.345
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Other Current Assets  13,16988,389101,558-68,78832,771339,373372,143-372,145-2



6.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets39,868,265
Total Liabilities27,585,965
Total Stockholder Equity12,282,300
 As reported
Total Liabilities 27,585,965
Total Stockholder Equity+ 12,282,300
Total Assets = 39,868,265

Assets

Total Assets39,868,265
Total Current Assets16,619,353
Long-term Assets23,248,912
Total Current Assets
Cash And Cash Equivalents 4,135,756
Net Receivables 5,618,478
Inventory 6,639,784
Total Current Assets  (as reported)16,619,353
Total Current Assets  (calculated)16,394,017
+/- 225,335
Long-term Assets
Property Plant Equipment 18,863,806
Intangible Assets 1,027,607
Long-term Assets  (as reported)23,248,912
Long-term Assets  (calculated)19,891,413
+/- 3,357,499

Liabilities & Shareholders' Equity

Total Current Liabilities12,318,707
Long-term Liabilities15,267,258
Total Stockholder Equity12,282,300
Total Current Liabilities
Short Long Term Debt 6,380,096
Accounts payable 2,563,850
Other Current Liabilities 321,973
Total Current Liabilities  (as reported)12,318,707
Total Current Liabilities  (calculated)9,265,919
+/- 3,052,788
Long-term Liabilities
Long term Debt 11,247,380
Capital Lease Obligations Min Short Term Debt157,852
Long-term Liabilities Other 1
Long-term Liabilities  (as reported)15,267,258
Long-term Liabilities  (calculated)11,405,233
+/- 3,862,025
Total Stockholder Equity
Total Stockholder Equity (as reported)12,282,300
Total Stockholder Equity (calculated)0
+/- 12,282,300
Other
Capital Stock6,235,406
Common Stock Shares Outstanding 62,354
Net Debt 13,491,720
Net Invested Capital 29,909,776
Net Working Capital 4,300,645
Property Plant and Equipment Gross 30,641,202



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
8,864,730
12,351,401
15,021,408
31,561,639
26,547,011
34,944,616
31,894,913
40,854,318
39,868,265
39,868,26540,854,31831,894,91334,944,61626,547,01131,561,63915,021,40812,351,4018,864,730
   > Total Current Assets 
6,537,788
9,004,732
9,700,687
8,979,287
6,347,697
15,969,643
13,269,553
16,190,078
16,619,353
16,619,35316,190,07813,269,55315,969,6436,347,6978,979,2879,700,6879,004,7326,537,788
       Cash And Cash Equivalents 
750,668
584,358
362,013
1,731,930
324,134
9,489,654
6,188,707
4,639,425
4,135,756
4,135,7564,639,4256,188,7079,489,654324,1341,731,930362,013584,358750,668
       Short-term Investments 
667,266
6,662,005
7,824,436
30,000
334,273
0
180,712
0
0
00180,7120334,27330,0007,824,4366,662,005667,266
       Net Receivables 
1,399,891
1,473,316
1,489,718
3,923,294
3,546,683
3,522,306
3,479,669
5,514,371
5,618,478
5,618,4785,514,3713,479,6693,522,3063,546,6833,923,2941,489,7181,473,3161,399,891
       Other Current Assets 
32,139
177,213
24,125
451,736
13,169
101,558
32,771
372,143
-2
-2372,14332,771101,55813,169451,73624,125177,21332,139
   > Long-term Assets 
0
0
0
0
0
18,974,973
18,625,360
24,664,239
23,248,912
23,248,91224,664,23918,625,36018,974,97300000
       Property Plant Equipment 
1,326,905
1,446,853
2,117,061
15,847,495
15,733,324
15,635,985
15,465,153
19,850,111
18,863,806
18,863,80619,850,11115,465,15315,635,98515,733,32415,847,4952,117,0611,446,8531,326,905
       Goodwill 
0
0
0
2,415,723
278,126
278,126
0
0
0
000278,126278,1262,415,723000
       Long Term Investments 
0
1,465,609
2,711,457
901,112
0
0
0
0
0
00000901,1122,711,4571,465,6090
       Intangible Assets 
37,209
119,533
138,860
2,848,589
2,849,369
2,347,810
1,916,302
1,479,040
1,027,607
1,027,6071,479,0401,916,3022,347,8102,849,3692,848,589138,860119,53337,209
       Long-term Assets Other 
0
0
0
0
0
0
-1
0
0
00-1000000
> Total Liabilities 
5,681,849
3,783,131
9,085,968
23,744,864
24,185,346
20,630,042
15,045,589
24,763,828
27,585,965
27,585,96524,763,82815,045,58920,630,04224,185,34623,744,8649,085,9683,783,1315,681,849
   > Total Current Liabilities 
3,901,160
2,813,828
4,454,604
5,603,292
16,159,346
7,661,618
4,865,108
13,103,617
12,318,707
12,318,70713,103,6174,865,1087,661,61816,159,3465,603,2924,454,6042,813,8283,901,160
       Short-term Debt 
746,890
0
3,633,158
1,834,800
1,811,764
1,513,304
1,500,000
1,550,000
0
01,550,0001,500,0001,513,3041,811,7641,834,8003,633,1580746,890
       Short Long Term Debt 
746,890
1,860,182
3,633,158
1,051,636
0
4,179,273
2,230,096
6,380,096
6,380,096
6,380,0966,380,0962,230,0964,179,27301,051,6363,633,1581,860,182746,890
       Accounts payable 
0
0
0
861,131
1,029,641
895,044
623,404
3,104,201
2,563,850
2,563,8503,104,201623,404895,0441,029,641861,131000
       Other Current Liabilities 
2,079,462
891,603
700,430
1,424,666
2,775,536
1,864,878
1,277,788
1,840,404
321,973
321,9731,840,4041,277,7881,864,8782,775,5361,424,666700,430891,6032,079,462
   > Long-term Liabilities 
0
0
0
0
0
12,968,425
9,550,304
11,660,212
15,267,258
15,267,25811,660,2129,550,30412,968,42500000
       Long term Debt Total 
0
132,150
3,501,008
12,371,509
3,735,488
8,766,518
5,559,739
7,457,759
0
07,457,7595,559,7398,766,5183,735,48812,371,5093,501,008132,1500
       Capital Lease Obligations 
0
0
0
0
0
186,056
198,763
129,603
157,852
157,852129,603198,763186,05600000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
1
100000000
       Deferred Long Term Liability 
73,691
55,268
0
943,338
1,150,171
890,741
663,269
435,797
0
0435,797663,269890,7411,150,171943,338055,26873,691
> Total Stockholder Equity
2,696,001
8,568,270
5,935,440
7,816,774
2,361,665
14,314,574
16,849,324
16,090,489
12,282,300
12,282,30016,090,48916,849,32414,314,5742,361,6657,816,7745,935,4408,568,2702,696,001
   Common Stock
2,323,336
3,021,871
3,171,871
3,578,432
3,578,432
4,721,022
6,185,406
6,210,406
0
06,210,4066,185,4064,721,0223,578,4323,578,4323,171,8713,021,8712,323,336
   Retained Earnings Total Equity000000000
   Accumulated Other Comprehensive Income 000000000
   Capital Surplus 
0
12,185,852
13,696,843
20,537,666
6,775,620
20,285,396
25,795,254
25,558,179
0
025,558,17925,795,25420,285,3966,775,62020,537,66613,696,84312,185,8520
   Treasury Stock00-110-110-110-110-11000
   Other Stockholders Equity 
45,927
115,263
167,071
110,251
110,251
303,025
182,012
175,158
0
0175,158182,012303,025110,251110,251167,071115,26345,927



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue26,033,025
Cost of Revenue-17,323,543
Gross Profit8,709,4828,709,482
 
Operating Income (+$)
Gross Profit8,709,482
Operating Expense-29,261,037
Operating Income-3,228,012-20,551,555
 
Operating Expense (+$)
Research Development2,377,176
Selling General Administrative6,945,952
Selling And Marketing Expenses0
Operating Expense29,261,0379,323,128
 
Net Interest Income (+$)
Interest Income111,268
Interest Expense-782,885
Other Finance Cost-0
Net Interest Income-671,617
 
Pretax Income (+$)
Operating Income-3,228,012
Net Interest Income-671,617
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,944,290-3,228,012
EBIT - interestExpense = -782,885
-3,748,515
-2,965,630
Interest Expense782,885
Earnings Before Interest and Taxes (EBIT)0-3,161,405
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-3,944,290
Tax Provision--195,776
Net Income From Continuing Ops-3,748,515-3,748,515
Net Income-3,748,515
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0671,617
 

Technical Analysis of IBKS No2 SPAC
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of IBKS No2 SPAC. The general trend of IBKS No2 SPAC is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine IBKS No2 SPAC's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of IBKS No2 SPAC.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1,050 < 1,063 < 1,106.

The bearish price targets are: 951.00 > 944.00 > 837.00.

Tweet this
IBKS No2 SPAC Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of IBKS No2 SPAC. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

IBKS No2 SPAC Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of IBKS No2 SPAC. The current macd is -8.60346032.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the IBKS No2 SPAC price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for IBKS No2 SPAC. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the IBKS No2 SPAC price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
IBKS No2 SPAC Daily Moving Average Convergence/Divergence (MACD) ChartIBKS No2 SPAC Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of IBKS No2 SPAC. The current adx is 21.63.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell IBKS No2 SPAC shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
IBKS No2 SPAC Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of IBKS No2 SPAC. The current sar is 986.85.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
IBKS No2 SPAC Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of IBKS No2 SPAC. The current rsi is 44.11. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
IBKS No2 SPAC Daily Relative Strength Index (RSI) ChartIBKS No2 SPAC Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of IBKS No2 SPAC. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the IBKS No2 SPAC price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
IBKS No2 SPAC Daily Stochastic Oscillator ChartIBKS No2 SPAC Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of IBKS No2 SPAC. The current cci is -72.27676484.

IBKS No2 SPAC Daily Commodity Channel Index (CCI) ChartIBKS No2 SPAC Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of IBKS No2 SPAC. The current cmo is -9.95646318.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
IBKS No2 SPAC Daily Chande Momentum Oscillator (CMO) ChartIBKS No2 SPAC Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of IBKS No2 SPAC. The current willr is -32.25806452.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that IBKS No2 SPAC is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
IBKS No2 SPAC Daily Williams %R ChartIBKS No2 SPAC Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of IBKS No2 SPAC.

IBKS No2 SPAC Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of IBKS No2 SPAC. The current atr is 27.60.

IBKS No2 SPAC Daily Average True Range (ATR) ChartIBKS No2 SPAC Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of IBKS No2 SPAC. The current obv is 75,881,586.

IBKS No2 SPAC Daily On-Balance Volume (OBV) ChartIBKS No2 SPAC Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of IBKS No2 SPAC. The current mfi is 28.83.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
IBKS No2 SPAC Daily Money Flow Index (MFI) ChartIBKS No2 SPAC Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for IBKS No2 SPAC.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-06MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

IBKS No2 SPAC Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of IBKS No2 SPAC based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.109
Ma 20Greater thanMa 50984.050
Ma 50Greater thanMa 100993.460
Ma 100Greater thanMa 2001,038.300
OpenGreater thanClose960.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of IBKS No2 SPAC with someone you think should read this too:
  • Are you bullish or bearish on IBKS No2 SPAC? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about IBKS No2 SPAC? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about IBKS No2 SPAC

I send you an email if I find something interesting about IBKS No2 SPAC.


Comments

How you think about this?

Leave a comment

Stay informed about IBKS No2 SPAC.

Receive notifications about IBKS No2 SPAC in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.